JPS6145619B2 - - Google Patents

Info

Publication number
JPS6145619B2
JPS6145619B2 JP52114193A JP11419377A JPS6145619B2 JP S6145619 B2 JPS6145619 B2 JP S6145619B2 JP 52114193 A JP52114193 A JP 52114193A JP 11419377 A JP11419377 A JP 11419377A JP S6145619 B2 JPS6145619 B2 JP S6145619B2
Authority
JP
Japan
Prior art keywords
dioxopyrimidine
carboxylate
ethyl
broad
fluoro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP52114193A
Other languages
English (en)
Japanese (ja)
Other versions
JPS5446791A (en
Inventor
Koichi Matsumura
Osamu Myashita
Hiroshi Shimazu
Naoto Hashimoto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Priority to JP11419377A priority Critical patent/JPS5446791A/ja
Priority to GB7836035A priority patent/GB2004545B/en
Priority to CH959178A priority patent/CH633537A5/fr
Priority to FR7826922A priority patent/FR2403999A1/fr
Priority to IT27934/78A priority patent/IT1099129B/it
Priority to US05/944,769 priority patent/US4190656A/en
Priority to DE19782841379 priority patent/DE2841379A1/de
Publication of JPS5446791A publication Critical patent/JPS5446791A/ja
Publication of JPS6145619B2 publication Critical patent/JPS6145619B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/20—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D239/22—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
JP11419377A 1977-09-22 1977-09-22 Fluorouracil derivative Granted JPS5446791A (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
JP11419377A JPS5446791A (en) 1977-09-22 1977-09-22 Fluorouracil derivative
GB7836035A GB2004545B (en) 1977-09-22 1978-09-07 Uracil derivatives and production thereof
CH959178A CH633537A5 (fr) 1977-09-22 1978-09-13 Derives uraciles et leur procede de fabrication.
FR7826922A FR2403999A1 (fr) 1977-09-22 1978-09-20 Derives de fluoro-uracile et procede de leur preparation ainsi que leur application pharmaceutique
IT27934/78A IT1099129B (it) 1977-09-22 1978-09-21 Derivati di uracile e loro produzione
US05/944,769 US4190656A (en) 1977-09-22 1978-09-22 Uracil derivatives and production thereof
DE19782841379 DE2841379A1 (de) 1977-09-22 1978-09-22 Uracilderivate, verfahren zu deren herstellung und arzneimittel

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP11419377A JPS5446791A (en) 1977-09-22 1977-09-22 Fluorouracil derivative

Publications (2)

Publication Number Publication Date
JPS5446791A JPS5446791A (en) 1979-04-12
JPS6145619B2 true JPS6145619B2 (enExample) 1986-10-08

Family

ID=14631520

Family Applications (1)

Application Number Title Priority Date Filing Date
JP11419377A Granted JPS5446791A (en) 1977-09-22 1977-09-22 Fluorouracil derivative

Country Status (7)

Country Link
US (1) US4190656A (enExample)
JP (1) JPS5446791A (enExample)
CH (1) CH633537A5 (enExample)
DE (1) DE2841379A1 (enExample)
FR (1) FR2403999A1 (enExample)
GB (1) GB2004545B (enExample)
IT (1) IT1099129B (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5913780A (ja) * 1982-07-13 1984-01-24 Takeda Chem Ind Ltd フルオロウラシル誘導体および抗腫瘍剤
JP2640664B2 (ja) * 1988-03-31 1997-08-13 クミアイ化学工業株式会社 ピリミジン誘導体及び除草剤

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3277092A (en) 1963-05-02 1966-10-04 Hoffmann La Roche 5, 6-substituted dihydro-5-fluoropyrimidines
US3360523A (en) * 1964-06-17 1967-12-26 Du Pont 3, 5, 6-substituted hydrouracils
US3406023A (en) * 1966-10-31 1968-10-15 Du Pont Herbicidal method
US3954758A (en) * 1970-05-27 1976-05-04 Pcr, Inc. Process for fluorinating uracil and derivatives thereof
CH553195A (de) * 1971-03-19 1974-08-30 Sandoz Ag Verfahren zur herstellung neuer 2,6-dichlor-benzaldoximo-(s-triazinyl-(6))-aether.
US3987045A (en) * 1971-05-03 1976-10-19 Basf Aktiengesellschaft Disperse dyes based on isoindolene derivatives
US3954759A (en) * 1972-07-13 1976-05-04 Pcr, Inc. Process for preparation of 6-substituted 5-fluorouracil derivatives
DE2401619C2 (de) * 1974-01-14 1986-04-03 Kailash Kumar Prof. Dr. 2359 Lentföhrden Gauri Fungistatisch wirksame Uracilderivate und Verfahren zu ihrer Herstellung
FR2298332A1 (fr) * 1975-01-22 1976-08-20 Asahi Chemical Ind Nouveaux derives de 5-fluorouraciles
US4071519A (en) * 1975-11-05 1978-01-31 Mitsui Toatsu Chemicals, Incorporated 1-Carbamoyl-5-fluorouracil derivatives
US4080455A (en) * 1975-12-16 1978-03-21 Taisho Pharmaceutical Company Limited 5-Fluoropyrimidin-4-one compositions

Also Published As

Publication number Publication date
FR2403999B1 (enExample) 1982-07-30
JPS5446791A (en) 1979-04-12
FR2403999A1 (fr) 1979-04-20
GB2004545B (en) 1982-04-07
CH633537A5 (fr) 1982-12-15
IT7827934A0 (it) 1978-09-21
GB2004545A (en) 1979-04-04
IT1099129B (it) 1985-09-18
DE2841379A1 (de) 1979-03-29
US4190656A (en) 1980-02-26

Similar Documents

Publication Publication Date Title
CN109678815B (zh) N-苄基苯甲酰胺类衍生物及其制备方法与制药用途
JP2002500666A (ja) 新規な化合物
JPH0737460B2 (ja) ピラノインドリジン誘導体及びその製造法
JPH034553B2 (enExample)
JPS63135384A (ja) Ｎ９−シクロペンチル−置換アデニン誘導体及びその製造方法
KR20010094731A (ko) 이미다졸 화합물 및 그의 의약 용도
JPH0314315B2 (enExample)
JPS6013788A (ja) 新規なクマリン誘導体
JPH04338383A (ja) 置換されたベンゾキサゼピン類及びベンゾチアゼピン類
JPH0739391B2 (ja) Ｎ−含有複素環化合物
JPS6216949B2 (enExample)
JPS6145619B2 (enExample)
JPS59210085A (ja) 新規エルゴリン誘導体の製造法
CN112225730B (zh) 一种稠环化合物的晶型、其组合物、制备方法及其应用
CN105949139B (zh) 一种仲丁基二苯基四嗪甲酰胺化合物及制备和应用
CN116867787A (zh) 吡唑并[3,4-d]嘧啶-3-酮衍生物
CN106432043B (zh) 2，3-吲哚二酮-3-n-烯基硝酮衍生物及其合成方法和应用
Brun et al. New approach to condensed pyrid-2-ones
CA1164862A (en) Indol acetic derivates, process for producing the same and pharmaceutical compositions comprising the same
KR820001543B1 (ko) 플루오로 우라실 유도체의 제조법
CN115626894B (zh) 一种具有镇痛活性的高乌甲素衍生物及其制备方法和应用
IE902836A1 (en) Substituted dibenzofurans and methods of using same
JPS6216489A (ja) ビンブラスチン型ビスインド−ルのニトロ誘導体
JPH0812676A (ja) ２−［（ピリジル置換）チオ］−カルバペネム誘導体
PT94390A (pt) Processo de preparacao de derivados da tioformamida e de composicoes farmaceuticas que os contem